VistaGen Therapeutics
VTGN
$4.62
Share price
2.67%
Change (1 day)
3,453.85%
Change (1 year)
Categories
Operating Margin for VistaGen Therapeutics (VTGN)
Operating Margin as of May 2024 (TTM): -17,500.60%
According to VistaGen Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -17,500.60%. At the end of 2022 the company had an Operating Margin of -4,306.88%.
Operating Margin history for VistaGen Therapeutics from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -4,306.88% | 161.87% |
| 2021 | -1,644.66% | |
| 2017 | -819.85% | |
| 2013 | -5,927.64% | 671.33% |
| 2012 | -768.49% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.